Filter Results :

Your search for Diabetes returned 186 reports

Sort by


Latin America Infusion Pump Market by Product (Volumetric, Syringe, Feeding, Insulin, PCA Pump), Application (Chemotherapy, Gastroenterology, Diabetes, Pain Management), Setting (Hospital, Ambulatory Centers), Accessories - Forecast to 2021

20 Sep 2016  |  Published by:  MarketsandMarkets
The Latin American infusion pumps and accessories market is estimated to reach USD 671.9 million by 2021, at a CAGR of 6.6% during the forecast period (2016 to 2021). The increasing prevalence of chronic diseases, owing to the rising geriatric population, increasing prevalence of chronic diseases, i...

$ 5,650.00

Read More

European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

11 Sep 2016  |  Published by:  iData Research Inc
The European diabetes diagnosis, treatment and drug delivery market increased in 2015 and growth is expected to persist over the forecast period. Market growth will be driven by the growing prevalence of diabetes in Europe and technological advancements made in certain segments, particularly insulin...

$ 4,995.00

Read More

Global Diabetes Partnering 2010 to 2016

01 Sep 2016  |  Published by:  CurrentPartnering
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry secto...

$ 1,995.00

Read More

Global Diabetes Management Market Report 2016

20 Aug 2016  |  Published by:  9Dimen Research
2016 Global Diabetes Management Report is a professional and in-depth research report on the world's major regional market conditions of the Diabetes Management industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).Th...

$ 2,850.00

Read More

Global Diabetes Care Devices Sales Market Report 2021

16 Aug 2016  |  Published by:  QYResearch
This report studies sales (consumption) of Diabetes Care Devices in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, cover...

$ 4,000.00

Read More

Global Diabetes Drugs Market Professional Survey Report 2016

15 Aug 2016  |  Published by:  QYResearch
Notes: Production, means the output of Diabetes Drugs Revenue, means the sales value of Diabetes Drugs This report studies Diabetes Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in th...

$ 3,500.00

Read More

Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth

01 Aug 2016  |  Published by:  GBI Research
SummaryDiabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia - high blood glucose levels - that results from defects in insulin secretion, insulin action, or a combination of these. This chronic hyperglycemia is associated with long-term damage, dy...

$ 4,995.00

Read More

Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment

01 Aug 2016  |  Published by:  GBI Research
SummaryDiabetes is a chronic metabolic disease characterized by hyperglycemia (high blood glucose levels) that results from defects in insulin secretion, insulin action, or both. Chronic hyperglycemia in diabetic patients is associated with long-term damage, dysfunction and failure o...

$ 4,995.00

Read More

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Pipeline Review, H2 2016

30 Jul 2016  |  Published by:  Global Markets Direct
SummaryIslet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Pipeline Review, H2 2016, provides in depth analysis on Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) targeted pipeline therapeut...

$ 3,500.00

Read More

Urinalysis Market by Product Type (Dipstick, Reagent, Analyzers, POC), Test Type (Biochemical, Sediment, Microscopic, Flow-Cytometric), Application (Diabetes, UTI, Kidney, Liver Disease, Pregnancy), End User (Hospitals, Diagnostic Labs) - Forecast to 2021

29 Jul 2016  |  Published by:  MarketsandMarkets
The urinalysis market is expected to reach USD 1.91 billion by 2021 from USD 1.32 billion in 2016, at a CAGR of 7.6%. The global urinalysis market is segmented based on product type, test type, applications, and end user. On the basis of product type, the urinalysis market is segmented into,...

$ 5,650.00

Read More

Patient Registry Software Market by Database Type (Drug, Device, Diabetes, Cancer, Asthma, CKD), Software (Integrated, Standalone), Delivery (On-Premise, Cloud), Functionality (PHM, HIE, POC) & End User (Government, Hospital, Pharma) - Forecasts to 2021

25 Jul 2016  |  Published by:  MarketsandMarkets
The patient registry software market is poised to reach USD 1,314.3 million by 2021 from USD 734.7 million in 2016 at a CAGR of 12.3% from 2016 to 2021. This market is categorized on the basis of product type, pricing model, deployment model, type of database, functionality, end user, and regi...

$ 5,650.00

Read More

Stem Cell Banking Market by Bank Type (Cord Blood, and Cord Tissue), Service (Collection & Transportation, Analysis, Processing, and Storage), Application (Cerebral Palsy, Leukemia, Thalassemia, Anemia, Autism, Diabetes), Region - Forecast to 2021

18 Jul 2016  |  Published by:  MarketsandMarkets
The global stem cell banking market is expected to reach USD 3.96 billion by 2021 from USD 1.58 billion in 2016, at a CAGR of 20.2% from 2016 to 2021. The storage services segment is expected to contribute the maximum share to the overall market in 2016. Advancements in cord blood preservation...

$ 5,650.00

Read More

Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021

01 Jul 2016  |  Published by:  MarketsandMarkets
The digital therapeutics market in terms of value is expected to reach USD 457.9 million by 2021 from USD 110 million in 2016, growing at a CAGR of 27.7% from 2016 to 2021. This market is categorized on the basis of application, sales channel, and region. Major factors contributing to the grow...

$ 5,650.00

Read More

Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016

08 Jun 2016  |  Published by:  Global Markets Direct
Summary‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016’, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Type 1 Diabetes (Juvenile Diabetes), complete with anal...

$ 2,000.00

Read More

EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2025

06 Jun 2016  |  Published by:  GlobalData
SummaryType 2 diabetes (T2D), formerly known as non-insulin dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose equilibrium that results from the body’s inability to make use of available insulin along with relative insulin deficiency. T2D constitutes appro...

$ 3,995.00

Read More
Total 186 records.